Breaking News
February 16, 2019 - Therapeutic endoscopy has an expanding role in the treatment of IBD
February 16, 2019 - Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
February 16, 2019 - Rerouting nerves during amputation reduces phantom limb pain before it starts
February 16, 2019 - A Hormone Produced When We Exercise Might Help Fight Alzheimer’s
February 16, 2019 - Millions of British people breathe toxic air travelling to GPs
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
February 16, 2019 - Testosterone is not the only hormone needed for penis development
February 16, 2019 - FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression
February 15, 2019 - Heart surgery technology developed at Baptist Health debuts after years of secrecy
February 15, 2019 - Prescription Opioids Double Risk of Triggering Fatal Car Crash
February 15, 2019 - New study helps doctors better understand high blood pressure in pregnant women
February 15, 2019 - Beta wave control in Parkinson’s diseased brain could be a potential therapy
February 15, 2019 - Media representations of love may justify gender-based violence in young people
February 15, 2019 - Yoga May Help With Rheumatoid Arthritis Symptoms, Severity
February 15, 2019 - Obstructive sleep apnea linked to inflammation, organ dysfunction
February 15, 2019 - Master your mind: A challenge from WELL for Life
February 15, 2019 - Why Some Brain Tumors Respond to Immunotherapy
February 15, 2019 - Must-Reads Of The Week From Brianna Labuskes
February 15, 2019 - Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s
February 15, 2019 - Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children
February 15, 2019 - Disruptive behavioral problems in kindergarten linked with lower employment earnings in adulthood
February 15, 2019 - New bioengineered device enhances the production of T-cells
February 15, 2019 - HDL proteome behaves like a tiny Velcro ball that is rolling on surfaces
February 15, 2019 - Puerto Rican children more likely to have poor or decreasing use of asthma inhalers
February 15, 2019 - Quality of patient care does not improve after physician-hospital integration
February 15, 2019 - Synopsys release new software for implant design and patient-specific planning
February 15, 2019 - 6 out of 10 hip replacements last 25 years or longer
February 15, 2019 - Health Tip: What You Should Know About Antibiotics
February 15, 2019 - New research challenges medical consensus that adenoids and tonsils significantly shrink during teenage years
February 15, 2019 - Discovery of weakness in a rare cancer could be exploited with drugs
February 15, 2019 - UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s
February 15, 2019 - New rules requiring female athletes to lower testosterone levels are based on flawed data
February 15, 2019 - Researchers comprehensively sequence the human immune system
February 15, 2019 - Researchers study animal venoms to identify new medicines for treating diseases
February 15, 2019 - Movement of wrist bones revealed by MRI and computer modeling
February 15, 2019 - Philips introduces new premium digital X-ray room to help shorten patient wait times
February 15, 2019 - Women fare worse than men following aortic heart surgery, study finds
February 15, 2019 - High-protein and low-calorie diet helps older adults lose weight safely, shows study
February 15, 2019 - Drug microdosing effects may not measure up to big expectations
February 15, 2019 - Discharged, Dismissed: ERs Often Miss Chance To Set Overdose Survivors On ‘Better Path’
February 15, 2019 - A digitized lab environment to be showcased at smartLAB 2019
February 15, 2019 - Scientists uncover main mechanisms of fluconazole drug resistance
February 15, 2019 - New study seeks to understand how colibactin causes cancer
February 15, 2019 - Photoacoustic imaging accurately measures the temperature of deep tissues
February 15, 2019 - Large study finds no association between phthalate exposure and breast cancer risk
February 15, 2019 - New research explains presence of ‘natural’ magnetism in human cells
February 15, 2019 - Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients
February 15, 2019 - Excessive daytime sleepiness in OSA patients linked to greater risk for cardiovascular diseases
February 15, 2019 - Scientists shed light on damaging cell effects linked to aging
February 15, 2019 - Celiac disease may be caused by stomach bug in childhood
February 15, 2019 - NHS performance figures highlight the true scale of Emergency Department crisis
February 15, 2019 - High intensity exercise may improve health by increasing gut microbiota diversity
February 15, 2019 - Apellis’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia
February 15, 2019 - Couples creating art or playing board games release ‘love hormone’
February 15, 2019 - Glimpsing The Future At Gargantuan Health Tech Showcase
February 15, 2019 - Common herbicide found to increase the risk of lymphoma
February 15, 2019 - Over-abundance of energy to cells could increase cancer risk
February 15, 2019 - Oxford Genetics appoints Jocelyne Bath as new Chief Operating Officer
February 15, 2019 - Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors
February 15, 2019 - Large-scale clinical trial begins to study liver transplantation between people with HIV
February 15, 2019 - Cannabis use among adolescents linked with increased risk of depression in adulthood
February 15, 2019 - Fractures, head injuries common in electric scooter accidents, UCLA study finds
February 15, 2019 - Prenatal maternal depression has important consequences for infant temperament, study shows
February 15, 2019 - Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer
February 15, 2019 - Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome
February 15, 2019 - Certain birthmarks warrant quick treatment, pediatricians say
February 15, 2019 - New machine learning method predicts if atypical ductal hyperplasia will turn cancerous
February 15, 2019 - Whole-genome sequencing and sharing real-time data could limit spread of foodborne bacteria
February 15, 2019 - FDA warns doctor for illegally marketing unapproved implantable device
February 15, 2019 - New injury documentation tool may provide better evidence for elder abuse cases
February 15, 2019 - Physiological age is a better predictor of survival than chronological age, shows study
February 15, 2019 - New study reveals high success rate for hip and knee replacements
February 15, 2019 - Prenatal exposures to BPA may pose threat to human ovarian function
February 15, 2019 - Suspicious spots on the lungs of children with rhabdomyosarcoma do not behave like metastases
February 15, 2019 - Diet drinks daily could raise stroke risk says study
February 15, 2019 - Many Systematic Reviews Do Not Fully Report Adverse Events
February 15, 2019 - Seven tips to protect your child from burns
February 15, 2019 - Keynote speakers announced for CBD Expo MIDWEST
Will a Defibrillator ‘Vest’ Protect Recent Heart Attack Patients?

Will a Defibrillator ‘Vest’ Protect Recent Heart Attack Patients?

image_pdfDownload PDFimage_print

THURSDAY, Sept. 27, 2018 — Wearable defibrillators do not lower the chances of dying from sudden cardiac arrest among high-risk patients who’ve just had a heart attack, a new investigation concludes.

Worn externally as a vest, these defibrillators are a noninvasive alternative to surgically implanted defibrillators. Both are designed to deliver a corrective electric shock to the heart if a heartbeat rhythm goes out of whack.

While implanted defibrillators are known to save lives in the months and years following a heart attack, “prior clinical trials have found that implantable cardioverter defibrillators did not lead to a survival benefit in the first 40 to 90 days” right after a heart attack, said cardiologist Dr. Gregg Fonarow.

So guidelines prohibit implantation during the first 40 days after a heart attack, or during the first 90 days among patients who’ve had bypass surgery or stent implantation, explained Fonarow. He is director of the Ahmanson-UCLA Cardiomyopathy Center and co-director of the UCLA Preventative Cardiology Program in Los Angeles, and was not involved with the new study.

According to Fonarow, despite a lack of solid proof, many cardiologists have operated under the assumption that wearable defibrillators could pick up the lifesaving slack in those early days after a heart attack.

Why? On the one hand, cardiac arrest is a big public health concern. Cardiac arrest, which is not the same as a heart attack, is caused when the heart’s electrical system malfunctions and the heart stops beating properly. The American Heart Association estimates it affects more than 350,000 non-hospitalized Americans every year.

What’s more, Fonarow stressed that the risk of cardiac arrest is “relatively high” in the immediate aftermath of a heart attack, particularly among those diagnosed with low “ejection fraction” (EF). In such patients, the heart’s left ventricle pumps out a relatively low amount of blood with every heartbeat.

In the new study, all 2,300 patients had an EF of 35 percent or less within a week after being discharged from the hospital following a heart attack. (A normal EF hovers between 50 to 65 percent).

About two-thirds of the study patients were trained to use a “LifeVest,” a combination harness/vest that is worn underneath clothing. One-third received usual care.

On average, the vest group wore the device 14 hours a day for up to three months. However, usage steadily decreased from 18 hours a day on average to 12 hours a day, and by the study’s end half the patients had stopped wearing it altogether.

Perhaps in part for that reason, the study team ultimately found no evidence that the vest helped to lower sudden cardiac death risk.

Fonarow described the study as “well conducted,” and suggested that it’s a good example of the fact that “many therapeutic strategies that seem plausible don’t actually work out the way intended when subjected to a rigorous clinical trial.”

Dr. Richard Page, who co-authored an editorial accompanying the study, suggested the findings are far from clear-cut.

Page noted, for example, that the study team also found that vest wearers saw their overall risk of dying from any cause drop by 35 percent.

Exactly why remains unclear. And Page acknowledged that while he “would like to say that the device played a role, we can’t, because it’s not the endpoint that the study was designed to test.”

But Page said he would still prescribe the vest “for a patient who I feel is at high risk and is highly motivated to wear the device.”

“This study was a heroic effort. But there is no question that these kinds of patients are at high risk for sudden cardiac arrest and death,” said Page. He is a clinical cardiac electrophysiologist and chair of the department of medicine at the University of Wisconsin’s School of Medicine and Public Health.

“And during this window of time after a heart attack, they are not eligible for an implantable device,” he continued.

“But this wearable device — if you’re actually wearing it — likely offers a very good chance, and almost your only chance, for saving your life if you have a cardiac arrest,” Page said.

The study was led by Dr. Jeffrey Olgin, who is chief of the division of cardiology at the University of California, San Francisco Center for the Prevention of Sudden Death.

Olgin and his colleagues published their findings in the Sept. 27 issue of the New England Journal of Medicine. The research was funded by the U.S. National Institutes of Health and LifeVest manufacturer Zoll Medical Corp.

More information

There’s more on sudden cardiac arrest at the American Heart Association.

© 2018 HealthDay. All rights reserved.

Posted: September 2018

Tagged with:

About author

Related Articles